These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15467351)

  • 1. The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis.
    Haase CG; Tinnefeld M; Faustmann PM
    Neuroimmunomodulation; 2004; 11(6):365-72. PubMed ID: 15467351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign multiple sclerosis is characterized by a stable neuroimmunologic network.
    Haase CG; Faustmann PM
    Neuroimmunomodulation; 2004; 11(4):273-7. PubMed ID: 15249735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient reported outcomes in benign multiple sclerosis.
    Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
    Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and psychosocial features of childhood and juvenile MS.
    Amato MP; Goretti B; Ghezzi A; Lori S; Zipoli V; Portaccio E; Moiola L; Falautano M; De Caro MF; Lopez M; Patti F; Vecchio R; Pozzilli C; Bianchi V; Roscio M; Comi G; Trojano M;
    Neurology; 2008 May; 70(20):1891-7. PubMed ID: 18474844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis.
    Ayatollahi P; Nafissi S; Eshraghian MR; Kaviani H; Tarazi A
    Mult Scler; 2007 Mar; 13(2):275-7. PubMed ID: 17439899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive functions in multiple sclerosis].
    Vicens A; Iriarte J; de Castro P; Castejón C; Martínez-Lage JM
    Neurologia; 1992; 7(7):171-5. PubMed ID: 1419085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.
    Yozbatiran N; Baskurt F; Baskurt Z; Ozakbas S; Idiman E
    J Neurol Sci; 2006 Jul; 246(1-2):117-22. PubMed ID: 16678208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive, but not mood dysfunction develops in multiple sclerosis during 7 years of follow-up.
    Haase CG; Tinnefeld M; Daum I; Ganz RE; Haupts M; Faustmann PM
    Eur Neurol; 2004; 52(2):92-5. PubMed ID: 15273430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
    Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
    Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study.
    Pokryszko-Dragan A; Zagrajek M; Slotwinski K; Gruszka E; Bilinska M; Podemski R
    Clin Neurol Neurosurg; 2009 Jul; 111(6):503-6. PubMed ID: 19233546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients.
    Simone IL; Ceccarelli A; Tortorella C; Bellacosa A; Pellegrini F; Plasmati I; De Caro MF; Lopez M; Girolamo F; Livrea P
    Health Qual Life Outcomes; 2006 Dec; 4():96. PubMed ID: 17163989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.